BioHarvest Sciences Inc. Stock Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
| Market Cap | 47.6M 41.25M 38.62M 35.24M 66.31M 4.54B 67.42M 453M 177M 2.27B 179M 175M 7.58B | P/E 2026 * |
-5.08x | P/E 2027 * | -18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 47.6M 41.25M 38.62M 35.24M 66.31M 4.54B 67.42M 453M 177M 2.27B 179M 175M 7.58B | EV / Sales 2026 * |
1.27x | EV / Sales 2027 * | 0.81x |
| Free-Float |
85.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioHarvest Sciences Inc.
| 1 day | +6.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
Zaki Rakib
CEO | Chief Executive Officer | 68 | 2026-04-28 |
Bar Dichter
DFI | Director of Finance/CFO | - | 2024-10-27 |
Ilana Belzer
COO | Chief Operating Officer | 65 | 2023-04-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Zaki Rakib
CHM | Chairman | 68 | 2018-09-26 |
Vivien Rakib
BRD | Director/Board Member | 67 | 2018-09-26 |
Jake Fiddick
BRD | Director/Board Member | 84 | 2019-02-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.06% | -2.94% | - | - | 47.6M | |
| -0.70% | -2.79% | -9.05% | -6.89% | 13.54B | |
| -0.81% | -3.21% | +4.93% | +2.37% | 5.11B | |
| -0.99% | -4.67% | -31.60% | -56.22% | 5.11B | |
| -0.12% | +0.90% | +5.57% | -29.80% | 4.18B | |
| -1.13% | -2.80% | -7.89% | -5.93% | 3.69B | |
| -0.93% | -4.47% | -3.06% | +3.55% | 3.54B | |
| -0.64% | -2.33% | -3.66% | +15.21% | 3.46B | |
| -0.44% | -1.00% | -12.80% | -15.78% | 2.48B | |
| +0.71% | -2.34% | -2.38% | +44.27% | 1.87B | |
| Average | +0.10% | -0.33% | -6.66% | -5.47% | 4.78B | |
| Weighted average by Cap. | -0.66% | -0.34% | -7.55% | -9.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.4M 32.41M 30.34M 27.69M 52.1M 3.57B 52.98M 356M 139M 1.79B 140M 137M 5.96B | 58.94M 51.08M 47.82M 43.63M 82.1M 5.62B 83.48M 561M 220M 2.81B 221M 216M 9.39B |
| Net income | -9.39M -8.13M -7.61M -6.95M -13.07M -895M -13.29M -89.28M -34.98M -448M -35.24M -34.47M -1.49B | -2.54M -2.2M -2.06M -1.88M -3.54M -242M -3.6M -24.17M -9.47M -121M -9.54M -9.33M -405M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
Select your edition
All financial news and data tailored to specific country editions
